<?xml encoding="utf-8" ?> A nationwide initiative to accelerate personalized cancer vaccine development is drawing fresh ...
Moderna stock popped 9% on Friday after the New York Times reported new details about an effort to speed up cancer vaccine ...
HSINCHU, Dec. 2, 2025 /PRNewswire/ -- Amaran Biotech, a next-generation Contract Development and Manufacturing Organization (CDMO), announced that its self-developed, GMP-grade high-purity vaccine ...
Vaccine and biotechnology names are leading a sharp sector rally, and a small protein-vaccine developer is posting the ...
The small biotech company Invivyd is developing an injectable, low-dose monoclonal antibody to protect against Covid.
In the early 2000s, immunologist Bali Pulendran started his lab at Emory University to explore the mechanisms underlying vaccine-mediated immunity. To uncover these processes, he focused on the yellow ...
Industry leaders and experts from across the globe will meet in Amsterdam to discuss advancements in research and development processes within the evolving vaccine industry. The event will address 12 ...
Lakshmi Srinivasan, PhD, former Executive Director and Head of Oncology Translational Medicine at Moderna, and Brandon Coder, ...
Vaxxinity Inc (ISIN: US92239B1035) develops innovative synthetic vaccine platforms targeting infectious diseases and oncology. North American investors should monitor clinical milestones and funding ...
Colombia’s €35 million EIB-backed VaxThera investment aims to strengthen domestic vaccine production, biotechnology research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results